Industry-Paid Studies Likely to Favor Company Drug
Sanofi Makes $0.69 Per Share Bid for Genzyme- Reports
Insurers and Rating Groups Post Information to Help Patients Choose Doctors
Voters Trust Drugs Made in USA, but Few are
Covering New Ground in Health System Shift
Study: Could Gut Germs Underlie Western Allergies?
Profit Squeeze Hits Drugmakers as Europe Crisis Leads to Cuts
SUBSCRIBE